Effect of polysaccharide from bacillus subtilis sp. on cardiovascular diseases and atherogenic indices in diabetic rats

BMC Complementary and Alternative Medicine

Volumn 16, Issue 1, 2016, Pages

  Ghoneim, Mona A M ^a   Hassan, Amal I ^a   Mahmoud, Manal G ^b   Asker, Mohsen S ^b  

^a NUCLEAR RESEARCH CENTER   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Bacillus subtilis; Cardiovascular disease; Diabetic; Exopolysaccharide; Lipid profile; Streptozotocin

Indexed keywords

EXOPOLYSACCHARIDE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN; ANTIDIABETIC AGENT; BACTERIAL POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACILLUS SUPPRESS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DPPH RADICAL SCAVENGING ASSAY; DRUG DETERMINATION; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; INFRARED SPECTROSCOPY; LIPOPROTEIN BLOOD LEVEL; MALE; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL PARAMETERS; RANDOMIZED CONTROLLED TRIAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SURVIVAL RATE; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ATHEROSCLEROSIS; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; DYSLIPIDEMIAS; SPRAGUE DAWLEY RAT;

ANIMALS; ATHEROSCLEROSIS; BACILLUS SUBTILIS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; DYSLIPIDEMIAS; HYPOGLYCEMIC AGENTS; MALE; POLYSACCHARIDES, BACTERIAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85008315296     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-016-1093-1     Document Type: Article

References (73)

1. Eiselein L, Schwartz HJ, Rutledge JC. The challenge of type 1 diabetes mellitus. ILAR J. 2004;45:231-6.
2. Shaw J, Sicree R, Zimmet P. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.
3. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year Diabetes Res Clin Pract. 2010;87:15-9.
4. Qiong L, Yizhong C, Jun Y, Mei S, Harold C. Hypoglycemic and hypolipidemic effects and antioxidant activity of fruit extracts from Lycium barbarum. Life Sci. 2004;76:137-49.
5. Erejuwa O. Effect of honey in diabetes mellitus: matters arising. J Diabetes Metab Disord. 2014;13:23.
6. Zhang YB, Zhao Y, Cui HF, Cao CY, Guo JY, Liu S. Comparison of hypoglycemic activity of fermented mushroom of Inonotus obliquus rich in vanadium and wild-growing I. obliquus. Biol Trace Elem Res. 2011;144:1351-7.
7. Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The Role of Oxidative Stress and Antioxidants in Diabetic Complications. Sultan Qaboos Univ Med J. 2012;12(1):5-18.
8. Stiles MC, Seaquist ER. Cerebral structural and functional changes in type 1 diabetes. Minerva Med. 2010;101:105-14.
9. Donot F, Fontana A, Baccou JC, Schorr-Galindo S. Microbial exopolysaccharides: main examples of synthesis, excretion, genetics and extraction. Carbohydr Polym. 2012;87:951-62.
10. Kim KJ, Lee OH, Han CK, Kim YC, Hong HD. Acidic polysaccharide extracts from Gastrodia Rhizomes Suppress the atherosclerosis risk index through inhibition of the serum cholesterol composition in Sprague Dawley rats fed a high-fat diet. Int J Mol Sci. 2012;13(2):1620-31.
11. Cabral De Melo FCB, Barsato D, Buzato JB, Celligoi MAPC. Levan from Bacillus subtilis natto: optimization of prod activity using factorial design. J Biotechnol. 2010;150S:S378.
12. Gummadi SN, Kumar K. Production of extracellular water insoluble ß-1,3- glucan (curdlan) from Bacillus sp. SNC07. Biotechnol Bioprocess Eng. 2005; 10(6):546-51.
13. Larpin S, Sauvageot N, Pichereau V, Laplace J, Auffray Y. Biosynthesis of exopolysaccharide by a Bacillus licheniformis strain isolated from ropy cider. Int J Food Microbiol. 2002;77:1-9.
14. Corsaro MM, Grant WD, Grant S, Marciano CE, Parrilli M. Structure determination of an exopolysaccharides from an alkaliphilic bacterium closely related to Bacillus spp. Eur J Biochem. 1999;264:554-61.
15. Kodali VP, Das S, Sen R. An EPS from a probiotic: biosynthesis dynamics, composition and emulsifying activity. Food Res Int. 2009;42:695-9.
16. Zheng H, Shen XQ, Bu GH, Luo YK. Effects of pH, temperature and enzymeto- substrate ratio on the antigenicity of whey protein hydrolysates prepared by alcalase. Int Dairy J. 2008;18:1028-33.
17. Kim YO, Kim HK, Bae KS, Yu JH, Oh TK. Purification and properties of a thermostable phytase from Bacillus sp. DS11. Enzyme Microb Technol. 1998; 22:2-7.
18. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem. 1965;28: 350-6.
19. Cappuccino JG, Sherman N. Microbiology laboratory manual. New Delhi: Pearson Education Inc.; 2004.
20. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol. 1991;173:697-703.
21. Tamura K, Dudley J, Nei M, Kumar S. Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596-9.
22. Jiang ZD, Jensen PR, Fenical W. Lobophorins A and B, new antiinflammatory macrolides produced by a tropical marine bacterium. Bioorg Med Chem Lett. 2003;9(14):2003-6.
23. Read RR, Costerton JW. Purification and characterization of adhesive exopolysaccharides from Pseudomonas putida and Pseudomonas fluorescens. Can J Microbiol. 1987;33:1080-90.
24. Asker MMS, Ahmed YM, Ramadan MF. Chemical characteristics and antioxidant activity of exopolysaccharides fractions from Microbacterium terre genes. Carbohydr Polym. 2009;77:563-7.
25. Sudhamani SR, Tharanathan RN, Prasad MS. Isolation and characterization of an extracellular polysaccharide from Pseudomonas caryophylli CFR 1705. Carbohydr Polym. 2004;56:423-7.
26. Filisetti-Cozzi TMC, Carpita C. Measurement of uronic acids without interference from neutral sugars. Anal Biochem. 1991;197:157-62.
27. Dodgson KS, Price RG. A note on the determination of the ester sulfate content of sulfated polysaccharides. Biochem J. 1962;84:106-10.
28. Morgan WT, Elson LA. A colorimetric method for the determination of Nacetylglucosamine and N-acetylchrondrosamine. Biochem J. 1934;28(3):988-95.
29. El-Sayed OH, Ismail SA, Ahmed YM, Abd El-Samei M, Asker MMS. Studies on the production of sulfated polysaccharide by locally isolated bacteria. Egypt Pharm J. 2007;4:439-52.
30. Ray B. Polysaccharides from Enteromorpha campressa: isolation, purification and structural features. Carbohydr Polym. 2006;66:408-16.
31. Jun HI, Lee H, Song GS, Kim YS. Characterization of the pectic polysaccharide from Pumpkin Peel LWT. Food Sci Technol. 2006;39:554-6.
32. You L, Gao Q, Feng M, Yang B, Ren J, Gu L, Cui C, Zhao M. Structural characterization of polysaccharides from Tricholoma matsutake and their antioxidant and antitumour activities. Food Chem. 2013;138:2242-9.
33. Asker MMS, Shawky BT. Structural characterization and antioxidant activity of an extracellular polysaccharide isolated from Brevibacterium otitidis BTS Food Chem. 2010;123:315-20.
34. Usta MF, Bivalacqua TJ, Yang DY, Ramanitharan A, Sell DR, Viswanathan A, et al. The protective effect of amino guanidine on erectile function in streptozotocin diabetic rats. J Urol. 2003;170:1437-42.
35. Sharma AK, Sharma A, Kumari R, Kishore K, Sharma D, Srinivasan PB, et al. Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats. J Biomed Res. 2012;26:200-10.
36. Lorke D. A new approach to tropical acute toxicity testing. Arch Toxicol. 1983;53:275-87.
37. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969;22:158-61.
38. Clark PM. Assays for insulin, proinsulin (s), and C-peptide. Ann Clin Biochem. 1999;36:541-64.
39. Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac troponin T for standardization of third generation troponin T methods. Scand J Clin Lab Invest. 1999;230:128-31.
40. Trinder P. Determination of serum cholesterol by enzymatic colorimetric method. Ann Clin Biochem. 1969;6:24-7.
41. Roechlau P, Bernt E, Gruber W. Kinetics of the cholesterol, sulfuric acid reaction. A fast kinetic method for serum cholesterol. Clin Chem Clin Biochem. 1974;12:403-8.
42. Assmann G. Cholesterol determination in high density lipoproteins separated by three different methods. Internist. 1979;20:595-604.
43. Haglund O, Luostarinen R, Wallin R, Wibell L, Saldeen T. The effect of fish oil triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin E. J Nutr. 1991;121:165-9.
44. Ishiguro H, Arinami T, Akazawa S, Enomoto M, Mitushio H, Fujishiro H, et al. Association study between the -141C Ins polymorphisms of the dopamine D2 receptor gene and alcoholism. Alcohol Clin Exp Res. 1998;22:845-8.
45. Bancroft JD, Stevens A. Theory and practice of histological techniques. 4th ed. New York: Churchill Livingstone, 1996.
46. Asker M, EL Sayed OH, Mahmoud MG, Ramadan MF. Chemical structure and antioxidant activity of a new exopolysaccharides produced from Micrococcus luteus. J Genet Eng Biotechnol. 2014;12(2):121-6.
47. De Paula ACCFF, Sousa RV, Figueiredo-Ribeiro RCL. Hypoglycemic activity of polysaccharide fractions containing bglucans from extracts of Rhynchelytrum repens (Willd.) C.E. Hubb., Poaceae. Braz J Med Biol Res. 2005;38:885-93.
48. Nichols MC, Bowman JP, Guezennec J. Effects of incubation temperature on growth and production of exopolysaccharides by an antarctic sea ice bacterium grown in batch culture. Appl Environ Microbiol. 2005;71(7):3519-23.
49. Guezennec J. Deep-sea hydrothermal vents: a new source of innovative bacterial exopolysaccharides of biotechnological interest? J Ind Microbiol Biotechnol. 2002;29:204-8.
50. Yukiko Y, Sogawa I, Nishina A. Improved hypolipidemic effects of xanthan gum-galactomannan mixtures in rats. Biosci Biotechnol Biochem. 2000;64: 2165-7.
51. Yu ZB, Wei H, Jin JP. Chronic coexistence of two troponin T isoforms in adult transgenic mouse cardiomyocytes decreased contractile kinetics and caused dilatative remodeling. Am J Physiol Cell Physiol. 2012;303:C24-32.
52. Rollet-Labelle E, Grange MJ, Elbim C, Marquetty C, Gougerot-Pocidalo MA, Pasquier C. Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis. Free Radic Biol Med. 1998;24(4): 563-72.
53. Gille L, Schott-Ohly P, Friesen N, Schulte im Walde S, Udilova N, Nowl H, Gleichmann H. Generation of hydroxyl radicals mediated by streptozotocin in pancreatic islets of mice in vitro. Pharmacol Toxicol. 2002;90(6):317-26.
54. Lemhadri A, Hajji L, Michel JB, Eddouks M. Cholesterol and triglycerides lowering activities of caraway fruits in normal and streptozotocin diabetic rats. J Ethnopharmacol. 2006;106:321-6.
55. Setsuta K, Kitahara Y, Arae M, Ohbayashi T, Seino Y, Mizuno K. Elevated cardiac troponin T predicts adverse outcomes in hypertensive patients. Int Heart J. 2011;52(3):164-9.
56. Soeda S, Ohmagari H, Shimeno H, Nagamatsu A. Preparation of aminated fucoidan and its evaluation as an antithrombotic and antilipemic agent. Biol Pharm Bull. 1994;17:784-8.
57. Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Atherosclerosis. 2001;158:12.
58. Bopanna KN, Kannan J, Sushma G, Balaraman R, Rathod SP. Antidiabetic and antihyperlipidemic effect of neem seed, kernal powder on alloxan diabetic rabbits. Indian J Pharm. 1997;9:162-7.
59. Ranganathan G, Li C, Kern PA. The translational regulation of lipoprotein lipase. J Biol Chem. 2001;272:2519-25.
60. Rajasekaran S, Jaykar B, Anandan R, Aboobacker KP, Vannamalar S. Antidiabetic activity of leaves of Zizyphus nummularia by dexamethasone induced diabetic rat model. Int J PharmTech Res. 2013;5(2):844-51.
61. Hassan S, Abd El-Twab S, Hetta M, Mahmoud B. Improvement of lipid profile and antioxidant of hypercholesterolemic albino rats by polysaccharides extracted from the green alga Ulva lactuca Linnaeus. Saudi J Biol Sci. 2011;18(4):333-40.
62. Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 2002;161(1):1-16.
63. Mustad VA, Etherton TD, Cooper AD, Mastro AM, Pearson TA, Jonnalagadda SS, et al. Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women. J Lipid Res. 1997;38(3):459-68.
64. Tabit CE, Chung WB, Hamburg NM, Vita JA. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord. 2010;11:61-74.
65. Satyanarayana U, Hakrapani CU. Biochemistry. 3rd ed. Kolkatta: Books and Allied (P) Ltd; 2007.
66. Shirwaikar A, Rajendran K, Kumar CD, Bodla R. Antidiabetic activity of aqueous leaf extracts of Annona squamosa in streptozotocin-nicotinamide type 2 diabetic rats. J Ethnopharmacol. 2004;91:171-5.
67. Stephen NJ. Relationship between LDL, HDL, blood pressure and atheroma progression in the coronaries. Curr Opin Lipidol. 2004;20:491-6.
68. Temme EH, Van HPG, Schouten EG, Kesteloot H. Effect of a plant sterolenriched spread on serum lipids and lipoprotein in mildly hypercholesterolaemic subjects. Acta Cardiol. 2002;57:111-5.
69. Linsel-Nitschke P, Tall AR. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov. 2005;4(3):193-205.
70. Singh SK, Kesari AN, Gupta RK, Jaiswal D, Watal G. Assessment of antidiabetic potential of Cynodon dactylon extract in streptozotocin diabetic rats. J Ethnopharmacol. 2007;114:174-9.
71. Hayat SA, Patel B, Khattar RS, Malik RA. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci. 2004;107:539-57.
72. Thent ZC, Lin TS, Das S, Zakaria Z. Histological changes in the heart and the proximal aorta in experimental diabetic rats fed with piper sarmentsoum. Afr J Tradit Complement Altern Med. 2012;9(3):396-404.
73. Malone JI, Schocken DD, Morrison AD, Gilbert-Barness E. Diabetic cardiomyopathy and carnitine deficiency. J Diabetes Complicat. 1999;13(2): 86-90.